HAI Book 2025 - Flipbook - Page 44
04:29 pm
The universal tau PET scale (Uni�㔏) for
Flortaucipir, MK6240, PI2620 and RO948
harmonization
04:30 pm - 05:25 pm
Poster Session 1B
05:25 pm - 07:30 pm
Networking Reception
Guilherme Povala, University of Pittsburgh,
Department of Psychiatry, Pittsburgh, PA, US
Thursday, January 16, 2025
08:15 am - 08:45 am
Mentoring Session
08:45 am - 10:00 am
ISTAART Collaborations Addressing
Accessibility and Acceptability of
Neuroimaging in Diverse Populations
08:45 am
Introduction
08:50 am
08:55 am
09:05 am
09:15 am
Background and collaboration
A-Frame: Actionable framework for
accessibility, acceptability and alliance in
aging imaging
Community-engaged research for increasing
representation in brain aging studies 3 the
HABS-HD approach and lessons learned
Neuroimaging of older Latino adults in Boston:
Linking established and new cohorts
09:25 am – 09:55 am
Discussion
09:55 am - 10:00 am
Concluding remarks and resources
10:00 am - 10:05 am
Blitz Session 2A Short Poster Presentations
10:00 am
Introduction
10:02 am
10:03 am
10:04 am
10:05 am - 11:00 am
The role of cohort heterogeneity in predicting
AD/ADRD cognitive decline
Sex moderates the association between
regional tau and longitudinal cognitive decline
in A4 and LEARN studies
Low tau in A´-positive cognitively impaired
individuals: Alzheimer9s disease or something
more?
Shana Stites, University of Pennsylvania,
Philadelphia, PA, USA
Tobey Betthauser, University of Wisconsin,
Madison, WI, USA
Reisa Sperling, Brigham and Women's
Hospital/HMS, Boston, MA, USA
Tobey Betthauser, University of Wisconsin,
Madison, WI, USA
Shana Stites, University of Pennsylvania,
Philadelphia, PA, USA
Sid O9Bryant, University of North Texas Health
Science Center, Fort Worth, TX, USA
Yakeel Quiroz, Massachusetts General Hospital,
Boston, MA, USA
Peiwei Liu, Department of Neuroscience,
University of California, Berkeley, Berkeley, CA,
US
Annie Li, Department of Neurology,
Massachusetts General Hospital, Harvard
Medical School, Boston, MA, US
Konstantinos Ioannou, Karolinska Institutet,
Stockholm, SE
Poster Session 2A (repeating in the afternoon as 2B) - Boards 59-116
11:00 am - 12:40 pm
SESSION IV Neuropath II
Keith Johnson, Massachusetts General Hospital,
Boston, MA, USA
Christina Moloney, Mayo Clinic, Jacksonville, FL,
USA
11:00 am - 11:05 am
Session Overview
Chairs
11:05 am
11:20 am
Understanding the mechanisms of synaptic
vesicle glycoprotein 2A change in Alzheimer's
disease
Association of [18F]Flortaucipir-PET and
plasma p-tau217 with tau neuropathology in AD
and other neurodegenerative disorders
HAI2025 - 44
Laetitia Lemoine, Perceptive, London, GB
Agathe Vrillon, University of California San
Francisco, San Francisco, CA, US
